GKOS Message Board Post 9873622 | Glaukos Corporation
home / stock / gkos / gkos message board
bulldog
(investorshub)
Posted on: Jun/25/2018 11:14:18
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141766850
Glaukos Announces FDA Approval for the iStent inject
News, Short Squeeze, Breakout and More Instantly...
-
Thursday, Glaukos Corporation (NYSE:GKOS) reported a first-quarter adjusted EPS loss of $(0.70), up from $(0.59) a year ago, missing the&...
-
U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday. Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sh...
-
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2024. Key highlights include: ...